The Syracuse Post-Standard on Monday examined how many health insurers have begun to encourage members to use generic versions of the anticholesterol medication Zocor, which reached the U.S. market last June, rather than Lipitor, manufactured by Pfizer, to reduce costs.
For example, Excellus BlueCross BlueShield of New York has begun to provide members with a one-month supply of simvastatin, the generic version of Zocor, at no cost and has reduced the cost of simvastatin for members to about $7.50 monthly, compared with about $135 monthly for Lipitor. Joel Owerbach, chief pharmacy officer for Excellus, said, "Lipitor is a great drug, but the reality is, for the vast majority of people who are taking Lipitor, you can get to the same place by taking a drug that's going to cost a lot less."

Source: Insurers Promote Use Of Generic Anticholesterol Drugs


Post a Comment

Google Analytics Alternative